Company
Krystal Biotech
Developing Genetic Medicines for High Unmet Medical Needs
Also known as Krystal Biotech, Inc.
- Status
- Operatingas of 2026-09-20Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Krystal Biotech, Inc.
- krystalbio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Krystal’s mission is to develop and deliver genetic medicines to patients using redosable gene therapies for the treatment of severe, life‑threatening or rare diseases that have limited or no approved therapies.
Funding snapshot
- Total raised
- $11.3MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $11.3M2017-08-08
Funding rounds
- Round, 2017
- $11.3M2017-08-08, SEC form D sold, 16 investors
About the company
- Status notes
- Commercial-Stage Company
Products
- Other
- VYJUVEK
Loading relationship preview